MEDIA RELEASE : MENINGOCOCCAL C VACCINES AT NAVESAU ADVENTIST HIGH SCHOOL TO BE ADMINISTERED ON 5TH APRIL
Medical teams from the Ministry of Health and Medical Services will be administering Meningococcal C (Men-C) vaccinations to all students who have been granted written consent from their parents at the Navesau Adventist High School starting tomorrow 5 April 2018.
The vaccination scheduled at the Navesau Adventist High School was initially scheduled to be held on 4 April 2018 as part of the Ministry of Health’s initial $10 million allocation towards combatting the spread of Men-C in Fiji. It was only due to the severe weather conditions caused by Tropical Cyclone Josie that the scheduled vaccination has been moved until tomorrow.
The Men-C vaccination that will be administered at the Navesau Adventist High School is the quadrivalent ACWY conjugate vaccine, Menactra. The Menactra vaccine is a proven preventative to the spread of Men-C and was used in Fiji last year to safely and effectively contain an outbreak of Men-C at the St. Johns College.
In order to receive the Men-C vaccinations, all students of the Navesau Adventist High School must provide signed consent forms from their parents to the medical team administering the vaccinations.
Medical teams from the Ministry of Health have already been on-site at Navesau Adventist High School since 19 March providing regular medical checks to students and staff and administering antibiotic regimens.
Medical staff will remain on school grounds to evaluate the status of students and staff at the Navesau Adventist School following the vaccine administration.
The Ministry urges all Fijians to help create clean, hygienic environments at home, schools and other communal spaces to help prevent the spread of Men-C and other bacterial diseases in Fiji. The Ministry also urges anyone experiencing the symptoms of Men-C to immediately go to the nearest health facility.